Home > Healthcare > Virus Filtration Market

Virus Filtration Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI3898

Virus Filtration Market Size is projected to grow exponentially during 2022 to 2028 due to the increasing prevalence of diseases, including diabetes, cancer and autoimmune disorders. According to the WHO, cancer accounted for around 10 million deaths in 2020 globally. Besides, cancer-causing infections, including human papillomavirus (HPV) and hepatitis contribute nearly 30% of cancer cases in low- and lower-middle-income countries.

Virus filtration offers a major line of defense against adventitious viruses and uses a membrane barrier to retain virus particles. Pharmaceutical companies have upped investments in virus filtration as it will play a monumental role in the safety of biopharmaceutical drug products. market participants expect North America and Europe to be the major markets as they continue to invest in new techniques.

Based on application, virus filtration market share from medical device segment will expand considerably during the forecast period of 2022-2028. The growth could be attributed to the demand for sophisticated virus clearance products. Companies are likely to focus on a product that not only meets quality standards but also ensures an optimized performance.

In terms of type, product segment will account for a considerable share of virus filtration market owing to the demand for kits, reagents and filters. These products are needed in the manufacturing of medical devices, biologics and research. Vendors and other stakeholders are expected to pour funds into research and development activities. Besides, reagents are likely to be sought to minimize the possible transmission of pathogenic viruses.

With respect to region, North America virus filtration market outlook will be strong over 2022-2028. Contract research organizations (CROs) and pharmaceutical and biotechnology companies are expected to invest in virus filtration offerings across the U.S. and Canada. Governments are expected to up their budgets and expand their healthcare infrastructure, boosting regional growth.

The competitive landscape of global virus filtration market suggests major industry players would emphasize organic and inorganic strategies, such as mergers & acquisitions, product launches, R&D activities and innovations. Some of the leading companies in the landscape are BioProcess International, General Electric Company, Asahi Kasei Medical Co., Ltd., Danaher, BIA Separations, Synder Filtration, Inc., Sotera Health, WuXi AppTec, Sartorius AG, Lonza and Merck KGaA, among others.

In April 2021, Asahi Kasei Medical Co., Ltd. expanded its business in China to boost the provision of coronavirus vaccines and therapies. The company expects its Planova filters to be sought-after amidst the development and mass production of anti-coronavirus agents.

In December 2020, Merck KGaA’s MilliporeSigma announced its contemplation to pour around USD 47 million in its production facilities in Massachusetts and New Hampshire. In April, the company had made plans to inject around USD 110 million to open a viral vector facility in California.

Impact of COVID-19 outbreak in global virus filtration market growth

The global COVID-19 pandemic has propelled the demand for virus filtration devices as kits and reagents continue to witness an unprecedented demand. Virus filtration has gained momentum as a robust step for the expansion of medical devices, stem cell products and vaccines & therapeutics. CROs and pharmaceutical companies are likely to further their investments in filters & filtration systems, auguring well for the industry outlook. Biotechnology companies are anticipated to invest in R&D as the demand for virus filtration technologies is probable to maintain its growth momentum in the coming years.

Several companies are likely to invest in technological advancements for reduced risk, flexibility and cost-savings. The COVID-19 outbreak has expedited the trend, with companies ramping up production to keep up with the global demand. Advanced techniques could enhance virus removal capability, integrity testing sensitivity and process robustness.

The virus filtration market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

Market, by Type

  • Product
    • Filters & Filtration Systems
    • Kits and Reagents
  • Services

Market, by Application

  • Biological
    • Vaccines & Therapeutics
    • Blood and Blood Products
    • Stem Cell Products
    • Others
  • Medical Devices
  • Others

Market, by End-use

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Medical Device Companies
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

What Information does this report contain?

Historical data coverage: 2017 to 2021; Growth Projections: 2022 to 2028.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.
Authors: Mariam Faizullabhoy

Buy Now

Access to only 1 person; cannot be shared; cannot be printed

Access for 2 to 5 users only within same department of one company

Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Buy Now

Access to only 1 person; cannot be shared; cannot be printed

Access for 2 to 5 users only within same department of one company

Access to a company wide audience; includes subsidiary companies or other companies within a group of companies